Vaxcyte, Inc. PCVX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vaxcyte, Inc.'s investment purchases?
- Vaxcyte, Inc. (PCVX) reported investment purchases of $584.13M in Q1 2026.
- How has Vaxcyte, Inc.'s investment purchases changed year-over-year?
- Vaxcyte, Inc.'s investment purchases increased by 85.7% year-over-year, from $314.49M to $584.13M.
- What is the long-term trend for Vaxcyte, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s investment purchases has grown at a 37.8% compound annual growth rate (CAGR), from $336.34M to $1.21B.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.